...
首页> 外文期刊>International journal of oncology >Tannic acid inhibits the Jak2/STAT3 pathway and induces G1/S arrest and mitochondrial apoptosis in YD-38 gingival cancer cells
【24h】

Tannic acid inhibits the Jak2/STAT3 pathway and induces G1/S arrest and mitochondrial apoptosis in YD-38 gingival cancer cells

机译:单宁酸抑制YD-38牙龈癌细胞中的Jak2 / STAT3途径并诱导G1 / S阻滞和线粒体凋亡

获取原文

摘要

Tannic acid (TA), is a potent anti-oxidant, showing anti-proliferative effects on numerous cancers. The ability of TA to induce proliferation inhibition on the rare tumor, gingival squamous cell carcinoma (GSCC), comprising <10% of all head and neck squamous cell carcinomas was studied in the YD-38 cell line. The main goal was to modulate the Jak2/STAT3 pathway using TA and to induce cell cycle arrest and apoptosis in GSCC. TA treatment induced G1 arrest and apoptosis in YD-38 cells. Molecular analysis revealed that TA inhibits Jak2/STAT3 pathway by preventing their expression as well as phosphorylation. This inhibition of STAT3 phosphorylation prevented the nuclear translocation and DNA binding capability of STAT3. Together with the inhibition of transcriptional regulatory function of STAT3, TA inhibited the expression of G1 phase modulators CDK-4, CDK-6, cyclin?D1 and cyclin?E. It is also evidenced that TA exerted an intense activation of p21Waf1/Cip1, p27Kip1 and p53 genes confirming its role in G1 phase inhibition. Additionally, upon treatment with TA, the expression of mitochondrial pore factors Bax, Bcl-2 and Bcl-XL were changed. We observed inhibition of Bcl-2 and an increase in mitochondrial localization of Bax leading to the loss of mitochondrial membrane potential, resulting in the release of cytochrome c to the cytosol. In addition, we perceived the activation of caspases upon TA treatment. Specific inhibition of caspase protected the cells from TA induced apoptosis. Taken together, this study reveals that TA significantly inhibits the Jak2/STAT3 signaling pathway and induces G1 arrest and mitochondrial apoptosis in YD-38 cells.
机译:单宁酸(TA)是一种有效的抗氧化剂,对多种癌症均具有抗增殖作用。在YD-38细胞系中研究了TA诱导对罕见肿瘤牙龈鳞状细胞癌(GSCC)的增殖抑制的能力,该癌症占所有头颈鳞状细胞癌的<10%。主要目标是使用TA调节Jak2 / STAT3途径,并诱导GSCC的细胞周期停滞和凋亡。 TA处理可诱导YD-38细胞中G1阻滞和凋亡。分子分析显示,TA通过阻止Jak2 / STAT3的表达和磷酸化而抑制Jak2 / STAT3途径。 STAT3磷酸化的这种抑制阻止了STAT3的核易位和DNA结合能力。 TA抑制STAT3的转录调节功能,同时抑制G1期调节剂CDK-4,CDK-6,cyclin?D1和cyclin?E的表达。也有证据表明TA发挥了p21Waf1 / Cip1,p27Kip1和p53基因的强烈激活,证实了其在G1期抑制中的作用。另外,用TA处理后,线粒体孔因子Bax,Bcl-2和Bcl-XL的表达发生了改变。我们观察到对Bcl-2的抑制作用以及Bax的线粒体定位增加导致线粒体膜电位丧失,从而导致细胞色素c释放到细胞质中。此外,我们认为TA治疗后胱天蛋白酶的活化。胱天蛋白酶的特异性抑制保护细胞免受TA诱导的凋亡。两者合计,这项研究表明TA显着抑制Jak2 / STAT3信号通路,并诱导YD-38细胞中G1阻滞和线粒体凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号